03-02-2012, 03:51 PM
| |||||||||
| |||||||||
 Keppra® Approved By FDA For Childhood Seizures! Keppra® Approved By FDA For Childhood Seizures! In the U.S., Keppra® has been approved as adjunctive therapy for partial onset seizures in adults and children aged four years and older with epilepsy. However the UCB recently announced that the U.S. Food and Drug Administration (FDA) has now approved to lower the age restriction to include infants from the age of one month and older with epilepsy. Professor Dr. Iris Loew-Friedrich, Chief Medical Officer and Executive Vice President UCB declared:
"As a leader in epilepsy UCB has a responsibility to develop effective medicines that address unmet medical needs. Our continuing development program with Keppra® in young children demonstrates our long-term commitment to epilepsy." The FDA granted their approval following a double blind, randomized, multi-centre, placebo-controlled phase III study, which assessed the efficacy and tolerability of Keppra® oral solution (20-50 mg/kg/day) in 116 pediatric patients with refractory partial onset seizures. The patients were aged between one month and four years or younger. Keppra® demonstrated a substantial reduction in the frequency of partial onset seizures during the 5-day evaluation period, with 43.1%in the Keppra® group experiencing a reduction of at least 50% in seizure frequency, compared with 19.6% in the placebo group(p=0.013). The researchers found that Keppra® was generally well tolerated by all pediatric patients, with the most commonly reported adverse events in 13.3% of patients in the Keppra group experiencing somnolence, compared with 1.8% in the placebo group, whilst 11.7% and 0% respectively suffered from irritability. Keppra® has been granted marketing authorization in the E.U. as adjunctive treatment of partial onset seizures in infants and young children aged one month to under four years in 2009, by the European Commission. UCB's growing epilepsy franchise has been based on Keppra® and has since been extended to include Vimpat® (lacosamide), an adjunctive therapy for the treatment of partial onset seizures in patients with epilepsy, which is marketed in the E.U. for those with epilepsy who are 17 years and older, and in the U.S. as a schedule V controlled substance for young adults with partial onset seizures with or without secondary generalization, aged 16 years and older.    |
|
03-02-2012, 07:46 PM
| #2 (permalink) | ||
| مراقبة قسم عالم الغرائب والعجائب
رﯜحـے ٺحبڪ .. ~» M 
 |  رد: Keppra® Approved By FDA For Childhood Seizures!
| ||
| |
|
03-02-2012, 11:40 PM
| #3 (permalink) | |
|
مراقبة قسم النقاش العام .. لم تعُد الحياه مُغريه ..
| رد: Keppra® Approved By FDA For Childhood Seizures!  السلام عليكم ورحمة اللهمشكووره ويعطييج العافيه على طرحج يا الغلاا  اجمل واحلى ورده لرووحج يا الحلوه  لا تبطيين علينا بيديدج خالفتج العافيـــــــــــــــــــــــــــه  | |
•
♫♪*‘ ڜفآفـة الاڛڷـﯣب, , والطبع يڛـכـر، [معڛـﯛڸــة المنطﯛقْ] ،ذﯢق ﯛذرآبـﮧ..!* ♫♪ • لديَ موعد مع القبرَ يا آل فزاع • وشآءت الأقدار (بقلمي) |
 |
| الذين يشاهدون محتوى الموضوع الآن : 1 ( الأعضاء 0 والزوار 1) | |
| أدوات الموضوع | |
| |
المواضيع المتشابهه | ||||
| الموضوع | كاتب الموضوع | المنتدى | مشاركات | آخر مشاركة |
| Febrile Seizures In Children May Be Triggered By Hyperventilation | Antigoni | الصحة والغذاء وأسرار الطب | 6 | 18-09-2011 07:16 PM |
| Sustained Efficacy Of Vimpat In Reducing Partial Onset Of Seizures For Up To 8 Years! | Antigoni | الصحة والغذاء وأسرار الطب | 6 | 05-09-2011 07:47 PM |
| Firazyr Approved For Acute Attacks Of Hereditary Angioedema! | Antigoni | الصحة والغذاء وأسرار الطب | 10 | 04-09-2011 12:31 PM |
| Epilepsy Surgery Could Help Many More Patients Who Struggle With Seizures! | Antigoni | الصحة والغذاء وأسرار الطب | 6 | 19-08-2011 01:37 PM |
| How To Prevent Seizures | Antigoni | الصحة والغذاء وأسرار الطب | 6 | 18-08-2011 02:23 PM |
|
الرئيسية | الأخبار |
معرض الصور | تواصل |
المنتدى | السيرة | البريد الالكتروني |
.. ^^
